Abstract
Hepatitis C virus (HCV) is a major risk factor for human hepatocellular carcinoma (HCC) but the mechanisms underlying HCV-induced carcinogenesis are still poorly understood. We have hypothesized that viral variants, selected during long-term infection, might contribute to cellular transformation. To address this issue, we have investigated the effect of natural HCV core variants isolated from liver tumors (T), or their non-tumor (NT) counterparts, on the tumor growth factor-β (TGF-β) pathway, a major regulator of cellular proliferation, differentiation and apoptosis. We have found a significant reduction in TGF-β reporter gene activity with the expression of core sequences isolated from liver tumors. In contrast, moderate or no effects were observed with non-tumor mutants or a core reference sequence. The molecular mechanisms have been characterized and involved the inhibition, by tumor-derived cores, of the DNA-binding activity of the Smad3/4 transcription factors complex. This inhibition occurs through a direct interaction between the central domain (amino acids 59–126) of tumor-derived core and the MH1 DNA-binding domain of Smad3, thus preventing its binding to DNA. We have therefore identified a new cell-signaling pathway targeted by HCV core and inhibited by tumor-derived core sequences. These results suggest that during chronic infection, there is selection of viral variants that may promote cell transformation by providing, to clonally expanding cells, resistance to TGF-β antiproliferative effects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alam SS, Nakamura T, Naganuma A, Nozaki A, Nouso K, Shimomura H and Kato N . (2002). Acta. Med. Okayama, 56, 141–147.
Arnulf B, Villemain A, Nicot C, Mordelet E, Charneau P, Kersual J, Zermati Y, Mauviel A, Bazarbachi A and Hermine O . (2002). Blood, 100, 4129–4138.
Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman MJ, Miyamura T and Brechot C . (1997). Proc. Nat. Acad. Sci. USA, 94, 1200–1205.
Bartenschlager R . (2004). Hepatology, 39, 835–838.
Bataller R, Paik YH, Lindquist JN, Lemasters JJ and Brenner DA . (2004). Gastroenterology, 126, 529–540.
Blight KJ, Kolykhalov AA and Rice CM . (2000). Science, 290, 1972–1974.
Bonnet MC, Weil R, Dam E, Hovanessian AG and Meurs EF . (2000). Mol. Cell. Biol., 20, 4532–4542.
Cheng PL, Chang MH, Chao CH and Lee YH . (2004). Oncogene, 23, 7821–7838.
Delhem N, Sabile A, Gajardo R, Podevin P, Abadie A, Blaton MA, Kremsdorf D, Beretta L and Brechot C . (2001). Oncogene, 20, 5836–5845.
Duvoux C, Pawlotsky JM, Bastie A, Cherqui D, Soussy CJ and Dhumeaux D . (1999). J. Hepatol., 31, 593–597.
Fukuda M, Kurosaki W, Yanagihara K, Kuratsune H and Sairenji T . (2002). Virology, 302, 310–320.
Kobayashi S, Hayashi H, Itoh Y, Asano T and Isono K . (1994). Cancer, 73, 48–52.
Kunkel M and Watowich SJ . (2004). FEBS Lett., 557, 174–180.
Kurokawa M, Mitani K, Irie K, Matsuyama T, Takahashi T, Chiba S, Yazaki Y, Matsumoto K and Hirai H . (1998). Nature, 394, 92–96.
Lai MMC and Ware CF . (1999). Curr. Top. Microbiol. Immunol., 242, 117–134.
Laporte J, Bain C, Maurel P, Inchauspe G, Agut H and Cahour A . (2003). Blood, 101, 52–57.
Lee DK, Kim BC, Brady JN, Jeang KT and Kim SJ . (2002a). J. Biol. Chem., 277, 33766–33775.
Lee DK, Kim BC, Kim IY, Cho EA, Satterwhite DJ and Kim SJ . (2002b). J. Biol. Chem., 277, 38557–38564.
Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA and Lemon SM . (2002). Gastroenterology, 122, 352–365.
Lerat H, Rumin S, Habersetzer F, Berby F, Trabaud MA, Trepo C and Inchauspe G . (1998). Blood, 91, 3841–3849.
Major ME and Feinstone SM . (1997). Hepatology, 25, 1527–1538.
Marcellin P, Asselah T and Boyer N . (2002). Hepatology, 36, S47–S56.
Massague J, Blain SW and Lo RS . (2000). Cell, 103, 295–309.
McLauchlan J, Lemberg MK, Hope G and Martoglio B . (2002). EMBO J., 21, 3980–3988.
Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T and Koike K . (1998). Nat. Med., 4, 1065–1067.
Nelson DR, Gonzalez-Peralta RP, Qian K, Xu Y, Marousis CG, Davis GL and Lau JY . (1997). J. Viral Hepat., 4, 29–35.
Neuman MG, Benhamou JP, Malkiewicz IM, Ibrahim A, Valla DC, Martinot-Peignoux M, Asselah T, Bourliere M, Katz GG, Shear NH and Marcellin P . (2002). J. Viral Hepat., 9, 134–140.
Nishihara A, Hanai J, Imamura T, Miyazono K and Kawabata M . (1999). J. Biol. Chem., 274, 28716–28723.
Ogata S, Florese RH, Nagano-Fujii M, Hidajat R, Deng L, Ku Y, Yoon S, Saito T, Kawata S and Hotta H . (2003). J. Clin. Microbiol., 41, 2835–2841.
Pavio N, Taylor DR and Lai MM . (2002). J. Virol., 76, 1265–1272.
Pellerin M, Lopez-Aguirre Y, Penin F, Dhumeaux D and Pawlotsky JM . (2004). J. Virol., 78, 4617–4627.
Polyak SJ, McArdle S, Liu SL, Sullivan DG, Chung M, Hofgartner WT, Carithers Jr RL, McMahon BJ, Mullins JI, Corey L and Gretch DR . (1998). J. Virol., 72, 4288–4296.
Ruster B, Zeuzem S, Krump-Konvalinkova V, Berg T, Jonas S, Severin K and Roth WK . (2001). J. Med. Virol., 63, 128–134.
Sabile A, Perlemuter G, Bono F, Kohara K, Demaugre F, Kohara M, Matsuura Y, Miyamura T, Brechot C and Barba G . (1999). Hepatology, 30, 1064–1076.
Schwer B, Ren S, Pietschmann T, Kartenbeck J, Kaehlcke K, Bartenschlager R, Yen TS and Ott M . (2004). J. Virol., 78, 7958–7968.
Shi Y and Massague J . (2003). Cell, 113, 685–700.
Shiffman ML . (2004). Semin. Liver Dis., 24, 1–2.
Taniguchi H, Kato N, Otsuka M, Goto T, Yoshida H, Shiratori Y and Omata M . (2004). J. Med. Virol., 72, 52–59.
Tellinghuisen TL and Rice CM . (2002). Curr. Opin. Microbiol., 5, 419–427.
Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Govindarajan S, Purcell RH and Chisari FV . (2002). Proc. Natl. Acad. Sci. USA, 99, 15661–15668.
Yasui K, Wakita T, Tsukiyama-Kohara K, Funahashi SI, Ichikawa M, Kajita T, Moradpour D, Wands JR and Kohara M . (1998). J. Virol., 72, 6048–6055.
Zemel R, Kazatsker A, Greif F, Ben-Ari Z, Greif H, Almog O and Tur-Kaspa R . (2000). Dig. Dis. Sci., 45, 2199–2202.
Acknowledgements
Support for this work was provided by INSERM, the European Community (VIRGIL), the Ligue Nationale Contre le Cancer (LNC), the Association pour la Recherche sur le Cancer (ARC) and the Agence Nationale de Recherches sur le Sida (ANRS). SB is a fellow from the Italian Government and we are grateful to Anna Linda Zignego for having SB working with us. NP was funded by ARC and INSERM. We thank MMC Lai for providing pCV-J4L6S plasmid and C Rice for the FL/Neo HCV replicon cell line. We thank Pr Hannoun, Pitie-Salpetriere Hospital, Paris and Serban Morosan for liver tissue samples.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Pavio, N., Battaglia, S., Boucreux, D. et al. Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-β pathway. Oncogene 24, 6119–6132 (2005). https://doi.org/10.1038/sj.onc.1208749
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208749
Keywords
This article is cited by
-
HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC
Clinical and Translational Oncology (2022)
-
Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis
Drugs (2021)
-
Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma
Journal of Biosciences (2017)
-
A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression
Cellular and Molecular Life Sciences (2014)
-
Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression
Tumor Biology (2014)